Zoetis Inc. (NYSE:ZTS) Shares Bought by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,257 shares of the company’s stock after purchasing an additional 93 shares during the period. CHICAGO TRUST Co NA’s holdings in Zoetis were worth $1,671,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Thomasville National Bank boosted its stake in Zoetis by 4.3% in the fourth quarter. Thomasville National Bank now owns 79,214 shares of the company’s stock valued at $12,906,000 after acquiring an additional 3,261 shares in the last quarter. Trust Co. of Toledo NA OH increased its position in Zoetis by 5.1% during the fourth quarter. Trust Co. of Toledo NA OH now owns 1,431 shares of the company’s stock worth $233,000 after buying an additional 70 shares during the period. Fiduciary Alliance LLC acquired a new stake in shares of Zoetis in the fourth quarter valued at approximately $663,000. Czech National Bank grew its position in shares of Zoetis by 6.0% during the fourth quarter. Czech National Bank now owns 97,822 shares of the company’s stock worth $15,938,000 after acquiring an additional 5,531 shares during the last quarter. Finally, Jacobs & Co. CA raised its position in Zoetis by 0.3% in the 4th quarter. Jacobs & Co. CA now owns 95,441 shares of the company’s stock valued at $15,550,000 after purchasing an additional 279 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ZTS shares. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. UBS Group assumed coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price target on the stock. JPMorgan Chase & Co. raised their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus cut their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Leerink Partners started coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $211.89.

Zoetis Trading Up 1.0 %

ZTS traded up $1.61 during midday trading on Monday, hitting $164.93. The company’s stock had a trading volume of 767,209 shares, compared to its average volume of 2,273,187. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The firm has a 50-day moving average price of $171.71 and a two-hundred day moving average price of $180.29. The firm has a market cap of $74.41 billion, a P/E ratio of 31.00, a PEG ratio of 2.91 and a beta of 0.89. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.36 EPS. On average, research analysts anticipate that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date is Tuesday, January 21st. This is an increase from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio (DPR) is currently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.